Antifungal Susceptibility Testing Practices at Acute Care Hospitals Enrolled in the National Healthcare Safety Network, United States, 2011–2015 | Zendy

Snigdha Vallabhaneni | Zendy; Mathew R. P. Sapiano | Zendy; Lindsey M. Weiner | Zendy; Shawn R. Lockhart | Zendy; Shelley S. Magill | Zendy

Open Access

Antifungal Susceptibility Testing Practices at Acute Care Hospitals Enrolled in the National Healthcare Safety Network, United States, 2011–2015

Author(s) -

Snigdha Vallabhaneni,

Mathew R. P. Sapiano,

Lindsey M. Weiner,

Shawn R. Lockhart,

Shelley S. Magill

Publication year - 2017

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofx175

Subject(s) - medicine , antifungal , acute care , health care , family medicine , intensive care medicine , dermatology , economics , economic growth

We assessed availability of antifungal susceptibility testing (AFST) at nearly 4000 acute care hospitals enrolled in the National Healthcare Safety Network. In 2015, 95% offered any AFST, 28% offered AFST at their own laboratory or at an affiliated medical center, and 33% offered reflexive AFST. Availability of AFST improved from 2011 to 2015, but substantial gaps exist in the availability of AFST.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research